Clinical Trials
6 trialsNCT00350948 2013-11-27
ASSIST-5
Telik
Phase 3 Terminated
NCT00022347 2013-06-26
TLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00102973 2012-05-31
TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer
Telik
Phase 3 Completed
NCT00038428 2011-07-25
Phase 2 Study of TLK286 in Platinum Resistant Advanced Epithelial Ovarian Cancer
Telik
Phase 2 Completed
NCT00051948 2011-07-25
TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian Cancer
Telik
Phase 1/2 Completed
NCT00052065 2011-07-25
TLK286 in Combination With Doxil in Platinum Refractory or Resistant Ovarian Cancer
Telik
Phase 1/2 Completed